Skip to main content

Incyte to Present at Upcoming Investor Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs Healthcare Conference on Monday, June 9, 2025 at 11:20 am (ET).

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.09
+1.34 (0.52%)
AAPL  354.95
+2.18 (0.62%)
AMD  504.15
-0.13 (-0.03%)
BAC  50.00
-0.08 (-0.16%)
GOOG  280.17
-1.09 (-0.39%)
META  623.77
-2.63 (-0.42%)
MSFT  510.93
-7.06 (-1.36%)
NVDA  155.21
-0.93 (-0.60%)
ORCL  118.00
-1.09 (-0.92%)
TSLA  381.73
+1.99 (0.52%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.